Showing 281-290 of 6808 results for "".
How to Recognize Physician Burnout
https://practicaldermatology.com/series/pa-perspectives/how-recognize-physician-burnout/29206/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses how to recognize physician burnout, and the importance of strategically adding breaks in your monthly schedule.Factor in Patient Satisfaction Matrix for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/factor-in-patient-satisfaction-matrix-for-best-results/20249/Chief Medical Editor Neil Bhatia, MD speaks with Maui Derm presenter and educator William P. Werschler, MD about cosmetic updates, including his “patient satisfaction matrix” that helps doctors and patients align on expectations of the outcomes of procedures.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.Blue Light: A Different Take
https://practicaldermatology.com/topics/acne-rosacea/blue-light-a-different-take/20088/Targeted blue light can have beneficial effects on the skin, says Terrence Keaney, MD. He discusses the types of questions he gets from patients about blue light and what the current data show about the efficacy of low-energy at-home blue light treatments, particularly for acne.Toxic Attitudes Toward Skin Bleaching
https://practicaldermatology.com/conferences/aad-2021/toxic-attitudes-toward-skin-bleaching/19925/Unregulated ingredients intended for skin lightening and bleaching range from the toxic to the simply unproven. Seemal Desai, MD says dermatologists should educate patients about physician-recommended, well-studied treatments and the risks of unregulated products. He highlights increased attention tPut your dermatology practice on the map with Google my Business
https://practicaldermatology.com/topics/practice-management/put-your-dermatology-practice-on-the-map-with-google-my-business/19633/Have you ever wondered why Google maps shows so much information about some dermatology practices, and so little about others? The answer is “Google my Business.” This video from Ekwa Marketing explains what it is, and how to optimize your profile.BTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiBehind the Scenes: Preparing to Inject
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aad-orlando-daily-coverage-day---wvpotpwa/18529/Live injection sessions are a great way to learn techniques and review injection anatomy for best outcomes and patient safety. Doris Day, MD speaks about these issues and shares her perspective on preparing to inject for these sessions.ASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologistAllergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.